BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Constâncio V, Nunes SP, Henrique R, Jerónimo C. DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types. Cells 2020;9:E624. [PMID: 32150897 DOI: 10.3390/cells9030624] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Qi Y, Qi L, Qiu M, Yao C, Zhang M, Lin J, Zheng Z, Chen C, Li H, Duan S. Hypermethylation of tumor necrosis factor decoy receptor gene in non-small cell lung cancer. Oncol Lett 2020;20:155-64. [PMID: 32565943 DOI: 10.3892/ol.2020.11565] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Schabort JJ, Nam AR, Lee KH, Kim SW, Lee JE, Cho JY. ANK2 Hypermethylation in Canine Mammary Tumors and Human Breast Cancer. Int J Mol Sci 2020;21:E8697. [PMID: 33218035 DOI: 10.3390/ijms21228697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Rykov SV, Filippova EA, Loginov VI, Braga EA. Gene Methylation in Circulating Cell-Free DNA from the Blood Plasma as Prognostic and Predictive Factor in Breast Cancer. Russ J Genet 2021;57:1239-52. [DOI: 10.1134/s1022795421110120] [Reference Citation Analysis]
4 Mastoraki S, Balgkouranidou I, Tsaroucha E, Klinakis A, Georgoulias V, Lianidou E. KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancer. Mol Oncol 2021;15:2412-22. [PMID: 33159839 DOI: 10.1002/1878-0261.12848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Carvalho Â, Ferreira G, Seixas D, Guimarães-Teixeira C, Henrique R, Monteiro FJ, Jerónimo C. Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation. Cancers (Basel) 2021;13:2101. [PMID: 33925308 DOI: 10.3390/cancers13092101] [Reference Citation Analysis]
6 Palanca-Ballester C, Rodriguez-Casanova A, Torres S, Calabuig-Fariñas S, Exposito F, Serrano D, Redin E, Valencia K, Jantus-Lewintre E, Diaz-Lagares A, Montuenga L, Sandoval J, Calvo A. Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies. Cancers (Basel) 2021;13:3016. [PMID: 34208598 DOI: 10.3390/cancers13123016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Jin S, Zhu D, Shao F, Chen S, Guo Y, Li K, Wang Y, Ding R, Gao L, Ma W, Lu T, Li D, Zhang Z, Cai S, Liang X, Song H, Ji L, Li J, Zheng Z, Jiang F, Wu X, Luan J, Zhang H, Yang Z, Cantor CR, Xu C, Ding C. Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy. Proc Natl Acad Sci U S A 2021;118:e2017421118. [PMID: 33495330 DOI: 10.1073/pnas.2017421118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
8 Siddiqui AS, Alshehri FA, Yaqinuddin A. Aberrant DNA Methylation in Bladder Cancer among Saudi Arabia Population. Journal of Health and Allied Sciences NU 2021;11:164-9. [DOI: 10.1055/s-0041-1726685] [Reference Citation Analysis]
9 Wu M, Shen H, Wang Z, Kanu N, Chen K. Research Progress on Postoperative Minimal/Molecular Residual Disease Detection in Lung Cancer. Chronic Diseases and Translational Medicine. [DOI: 10.1002/cdt3.10] [Reference Citation Analysis]
10 Raos D, Ulamec M, Katusic Bojanac A, Bulic-Jakus F, Jezek D, Sincic N. Epigenetically inactivated RASSF1A as a tumor biomarker. Bosn J Basic Med Sci 2021;21:386-97. [PMID: 33175673 DOI: 10.17305/bjbms.2020.5219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sequeira JP, Constâncio V, Lobo J, Henrique R, Jerónimo C. Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma. Cancers (Basel) 2021;13:5252. [PMID: 34771419 DOI: 10.3390/cancers13215252] [Reference Citation Analysis]
12 Aleotti V, Catoni C, Poggiana C, Rosato A, Facchinetti A, Scaini MC. Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy. Cancers (Basel) 2021;13:6217. [PMID: 34944843 DOI: 10.3390/cancers13246217] [Reference Citation Analysis]
13 Mendaza S, Guerrero-Setas D, Monreal-Santesteban I, Ulazia-Garmendia A, Cordoba Iturriagagoitia A, De la Cruz S, Martín-Sánchez E. A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis. Biomedicines 2021;9:1394. [PMID: 34680511 DOI: 10.3390/biomedicines9101394] [Reference Citation Analysis]
14 Gutierrez A, Demond H, Brebi P, Ili CG. Novel Methylation Biomarkers for Colorectal Cancer Prognosis. Biomolecules 2021;11:1722. [PMID: 34827720 DOI: 10.3390/biom11111722] [Reference Citation Analysis]
15 Hofman P. Liquid biopsy for lung cancer screening: Usefulness of circulating tumor cells and other circulating blood biomarkers. Cancer Cytopathol 2021;129:341-6. [PMID: 33007153 DOI: 10.1002/cncy.22367] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Almeida-Lousada H, Mestre A, Ramalhete S, Price AJ, de Mello RA, Marreiros AD, Neves RPD, Castelo-Branco P. Screening for Colorectal Cancer Leading into a New Decade: The "Roaring '20s" for Epigenetic Biomarkers? Curr Oncol 2021;28:4874-93. [PMID: 34898591 DOI: 10.3390/curroncol28060411] [Reference Citation Analysis]
17 Galardi F, Luca F, Romagnoli D, Biagioni C, Moretti E, Biganzoli L, Leo AD, Migliaccio I, Malorni L, Benelli M. Cell-Free DNA-Methylation-Based Methods and Applications in Oncology. Biomolecules 2020;10:E1677. [PMID: 33334040 DOI: 10.3390/biom10121677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
18 Liang Y, Lei Y, Du M, Liang M, Liu Z, Li X, Gao Y. The increased expression and aberrant methylation of SHC1 in non-small cell lung cancer: Integrative analysis of clinical and bioinformatics databases. J Cell Mol Med 2021;25:7039-51. [PMID: 34117717 DOI: 10.1111/jcmm.16717] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Krasic J, Abramovic I, Vrtaric A, Nikolac Gabaj N, Kralik-Oguic S, Katusic Bojanac A, Jezek D, Sincic N. Impact of Preanalytical and Analytical Methods on Cell-Free DNA Diagnostics. Front Cell Dev Biol 2021;9:686149. [PMID: 34552921 DOI: 10.3389/fcell.2021.686149] [Reference Citation Analysis]
20 Lobo J, Constâncio V, Leite-Silva P, Guimarães R, Cantante M, Braga I, Maurício J, Looijenga LHJ, Henrique R, Jerónimo C. Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples. Clin Epigenetics 2021;13:70. [PMID: 33823933 DOI: 10.1186/s13148-021-01048-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Guemri J, Pierre-Jean M, Brohard S, Oussada N, Horgues C, Bonnet E, Mauger F, Deleuze JF. Methylated ccfDNA from plasma biomarkers of Alzheimer's disease using targeted bisulfite sequencing. Epigenomics 2022. [PMID: 35416052 DOI: 10.2217/epi-2021-0491] [Reference Citation Analysis]
22 Yang J, Wang J, Li H, Gao S, Fan Y, Wang K. IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma. Front Oncol 2022;12:746643. [DOI: 10.3389/fonc.2022.746643] [Reference Citation Analysis]
23 Lobo J, Constâncio V, Guimarães-Teixeira C, Leite-Silva P, Miranda-Gonçalves V, Sequeira JP, Pistoni L, Guimarães R, Cantante M, Braga I, Maurício J, Looijenga LHJ, Henrique R, Jerónimo C. Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors. Mol Oncol 2021;15:846-65. [PMID: 33513287 DOI: 10.1002/1878-0261.12909] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
24 Wang Y, Lin X, Sun D. A narrative review of prognosis prediction models for non-small cell lung cancer: what kind of predictors should be selected and how to improve models? Ann Transl Med 2021;9:1597. [PMID: 34790803 DOI: 10.21037/atm-21-4733] [Reference Citation Analysis]
25 Faldoni FLC, Rainho CA, Rogatto SR. Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives. Cells 2020;9:E1164. [PMID: 32397183 DOI: 10.3390/cells9051164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Winter J, Sheehan-hennessy L, Yao B, Pedersen S, Wassie M, Eaton M, Chong M, Young G, Symonds E. Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patients. CBM 2022. [DOI: 10.3233/cbm-210399] [Reference Citation Analysis]
27 Wang LJ, Han Q, Qiu JG, Zhang CY. Cooperative In Situ Assembly of G-Quadruplex DNAzyme Nanowires for One-Step Sensing of CpG Methylation in Human Genomes. Nano Lett 2021. [PMID: 34931851 DOI: 10.1021/acs.nanolett.1c03969] [Reference Citation Analysis]
28 Wagner W. How to Translate DNA Methylation Biomarkers Into Clinical Practice. Front Cell Dev Biol 2022;10:854797. [DOI: 10.3389/fcell.2022.854797] [Reference Citation Analysis]
29 Carvalho Â, Guimarães-Teixeira C, Constâncio V, Fernandes M, Macedo-Silva C, Henrique R, Monteiro FJ, Jerónimo C. One sample fits all: a microfluidic-assisted methodology for label-free isolation of CTCs with downstream methylation analysis of cfDNA in lung cancer. Biomater Sci 2022. [PMID: 35583893 DOI: 10.1039/d2bm00044j] [Reference Citation Analysis]
30 Constantin N, Sina AAI, Korbie D, Trau M. Opportunities for Early Cancer Detection: The Rise of ctDNA Methylation-Based Pan-Cancer Screening Technologies. Epigenomes 2022;6:6. [DOI: 10.3390/epigenomes6010006] [Reference Citation Analysis]
31 Mio C, Damante G. Challenges in promoter methylation analysis in the new era of translational oncology: a focus on liquid biopsy. Biochim Biophys Acta Mol Basis Dis 2022;1868:166390. [PMID: 35296416 DOI: 10.1016/j.bbadis.2022.166390] [Reference Citation Analysis]
32 Augustus E, Zwaenepoel K, Siozopoulou V, Raskin J, Jordaens S, Baggerman G, Sorber L, Roeyen G, Peeters M, Pauwels P. Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy-The Role of Liquid Biopsy in Unraveling the Puzzle. Cancers (Basel) 2021;13:1675. [PMID: 33918147 DOI: 10.3390/cancers13071675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Cristall K, Bidard FC, Pierga JY, Rauh MJ, Popova T, Sebbag C, Lantz O, Stern MH, Mueller CR. A DNA methylation-based liquid biopsy for triple-negative breast cancer. NPJ Precis Oncol 2021;5:53. [PMID: 34135468 DOI: 10.1038/s41698-021-00198-9] [Reference Citation Analysis]
34 Diefenbach RJ, Lee JH, Rizos H. Methylated circulating tumor DNA as a biomarker in cutaneous melanoma. Melanoma Manag 2020;7:MMT46. [PMID: 32922728 DOI: 10.2217/mmt-2020-0010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Mahmood W, Erichsen L, Ott P, Schulz WA, Fischer JC, Arauzo-Bravo MJ, Bendhack ML, Hassan M, Santourlidis S. Aging-associated distinctive DNA methylation changes of LINE-1 retrotransposons in pure cell-free DNA from human blood. Sci Rep 2020;10:22127. [PMID: 33335196 DOI: 10.1038/s41598-020-79126-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Zhong X, Zhong G. Prognostic biomarker identification and tumor classification in breast cancer patients by methylation and transcriptome analysis. FEBS Open Bio 2021. [PMID: 34056873 DOI: 10.1002/2211-5463.13211] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Guo XM, Miller H, Matsuo K, Roman LD, Salhia B. Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature. Cancers (Basel) 2021;13:838. [PMID: 33671298 DOI: 10.3390/cancers13040838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Tang Y, Tang Q, Wei H, Hu P, Zou D, Liang R, Ling Y. Hub Genes Associated with the Diagnosis of Diabetic Retinopathy. Int J Gen Med 2021;14:1739-50. [PMID: 33986612 DOI: 10.2147/IJGM.S311683] [Reference Citation Analysis]